Genkyotex
ID: 17653477Drug development platform targeting NOX enzymes to prevent oxygen radical production.
4
Funding Rounds
$51.8m
Money raised
Recent Funding Rounds
Overview
Drug development platform targeting NOX enzymes to prevent oxygen radical production.
- Business model: B2B
- Headquarters: Geneva
- Social accounts: linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
Funding
Funding series
Funding Series Analysis
The company Genkyotex has raised a total of $51.77m in funding over 4 rounds.
Key Insights:
- GenKyoTex Series C round, July 2012: $26m
- GenKyoTex Series C round, May 2011: $20.4m
- GenKyoTex funding round, May 2008: $3.82m
- GenKyoTex funding round, January 2006: $1.55m
Industries
Genkyotex is active in the following industries: